Exigence IT is an IT service provider specialising in the biotechnology, pharmaceutical and health sector, encompassing on-premise, cloud and hybrid systems, and providing the development, implementation and support of bespoke solutions.
New innovations in health are appearing every day. What was an industry dominated by large companies producing drugs and devices is now diversifying.
A novel mentoring program is leading the way in giving PhD students a better understanding of the commercial and industrial world of science, technology, engineering and mathematics (STEM).
Cook Medical is one of a few companies in the world to make custom (hand-sewn) aortic stents that aim to improve the outcomes for patients requiring endovascular repair worldwide and is an Australian (Brisbane) manufacturing and medical success story.
Sanofi Pasteur and the University of Melbourne are engaging in an agreement co-funding Proof-of-Concept studies - core to the University's capability and of strategic interest to Sanofi Pasteur - covering programs in infectious diseases, microbiology, and immunology, in a project running from 2014 to 2017.
Atomo Diagnostics is a specialist medical diagnostic device company that is emerging as a leading innovator in the field of rapid diagnostic testing.
The Medical Device Partnering Program (MDPP) at Flinders University fosters collaborations between inventors, researchers, industry, manufacturers, end-users and government, to help develop cutting-edge medical devices.
Startup SpeeDx - a Sydney based company founded in 2009 - have developed a new clinical testing technology finding a solution to the growing threat of drug resistance.
As the Australian Federal Government 'My Heath Record' initiative rolls out nationally, nowhere are the challenges of distance greater than in the Northern Territory, Australia's most sparsely populated state.
Extensia, an Australian supplier of software solutions and technologies for the healthcare sector, have developed a digital solution for more efficient healthcare delivery.
Rhinomed and BOC Ltd collaborated to provide people with sleeping issues a simple and affordable solution.
Amgen Australia conducts on average two ‘first in human’ studies every year, with almost half of their clinical trial research being early phase.